BeStock  

United Therapeutics UTHR

US equityMarket cap rank #819Drug Manufacturers - Specialty & Generic
$554.73 −$4.37 (-0.78%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $550.23 -0.81%
Open$561.20
Prev close$559.10
Day range$551.77 – $563.12
Volume531.8K
Market cap$23.63B
P/E (TTM)20.9
Dividend yield–
Founded1996
CEODr. Martine A. Rothblatt, J.D.,M.B.A.,PhD
Employees1,400
HeadquartersSilver Spring, United States of America
Websitewww.unither.com

Revenue per employee

$1.5M$1.8M$2.1M$2.3MDec '18Dec '21Dec '25

1,400 employees as of 2025/FY (+7.3% YoY). Revenue per employee is total revenue divided by headcount — a rough productivity gauge, not a per-worker pay figure.

Management team

Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD Chairperson of the Board and Chief Executive Officer
Age 71 · Total comp. $18,038,972.00 · As of 28 Apr 2026
Background

Martine Rothblatt, Ph.D., J.D., M.B.A., Career Highlights: United Therapeutics - Founder, Chairperson & CEO (1996-present); SiriusXM - Founder. Other Professional Experience and Achievements: Author: Your Life or Mine: How Geoethics Can Resolve the Conflict Between Private and Public Interests in Xenotransplantation (anticipated the need both for global virus bio-surveillance and a greatly expanded supply of transplantable organs) and Virtually Human (AI ethics and human-machine issues)Author: Your Life or Mine: How Geoethics Can Resolve the Conflict Between Private and Public Interests in Xenotransplantation (anticipated the need both for global virus bio-surveillance and a greatly expanded supply of transplantable organs) and Virtually Human (AI ethics and human-machine issues); Co-inventor of 10 U.S. patents (additional patents pending); UCLA Medal (2018); Benjamin Franklin Medal for Distinguished Achievement in the Sciences (2023); National Business Aviation Association Meritorious Service to Aviation Award (2021); No. 8 on Forbes' inaugural Innovator 250 List, recognizing the 250 living Americans who best embody the nation's creative spirit. (2026); Member of National Academy of Engineering, among the highest professional distinctions accorded to an engineer (2026). Other Current Public Company Boards: BETA Technologies, Inc. Education: B.S., Communications, M.B.A., and J.D., University of California, Los Angeles; Ph.D., Medical Ethics, University of London.

Michael Benkowitz President and Chief Operating Officer
Age 54 · Total comp. $14,385,655.00 · As of 28 Apr 2026
Background

Mr. Benkowitz joined United Therapeutics in 2011 as our Executive Vice President, Organizational Development, and was promoted to President and Chief Operating Officer in 2016. He is responsible for all of our sales, marketing, market access, patient relations, manufacturing, medical affairs, and corporate compliance activities, most company-wide administrative functions, including human resources and information technology, many of our business development efforts, and several of our key business alliances and partnerships.

James C. Edgemond Chief Financial Officer, Principal Accounting Officer and Treasurer
Age 59 · Total comp. $8,348,367.00 · As of 28 Apr 2026
Background

Mr. Edgemond joined United Therapeutics in January 2013 as Treasurer and Vice President, Strategic Financial Planning. Mr. Edgemond was promoted to Chief Financial Officer and Treasurer in March 2015. Prior to joining United Therapeutics, he was Vice President, Corporate Controller, and Treasurer of Clark Construction Group from 2008 through January 2013. He also served in a variety of roles at The Corporate Executive Board Company from 1998 to 2008, including as Executive Director, Finance from 2005 to 2008. He began his career as a public accountant at KPMG Peat Marwick LLP, from 1990 through 1998, where he served in a variety of roles, including as a Senior Manager prior to his departure.

Paul A. Mahon,J.D. Executive Vice President, General Counsel and Corporate Secretary
Age 62 · Total comp. $5,531,313.00 · As of 28 Apr 2026
Background

Mr. Mahon has served as General Counsel and Corporate Secretary of United Therapeutics since its inception in 1996. In 2001, Mr. Mahon joined United Therapeutics full-time as Senior Vice President, General Counsel and Corporate Secretary. In 2003, Mr. Mahon was promoted to Executive Vice President, General Counsel, and Corporate Secretary. Prior to 2001, he served United Therapeutics, beginning with its formation in 1996, in his capacity as principal and managing partner of a law firm specializing in technology and media law.

Nilda Mesa, J.D. Independent Director
Age 66 · Total comp. $697,201.00 · As of 28 Apr 2026
Background

Ms. Nilda Mesa, J.D., Career Highlights: New York City Mayor's Office - Director, Mayor's Office of Sustainability; led OneNYC, the pathbreaking long-term sustainability plan for the city and oversaw programs in climate, energy, sustainability, air quality and public health, waste, green buildings, transportation, public education, and other initiatives (2014-2016). Columbia University - Adjunct Professor, School of International and Public Affairs (2016-2025); Director, Urban Sustainability and Equity Planning Program (2018-2025); Chief Administrative Officer at the Columbia Journalism School (2012-2014). Other Professional Experience and Achievements: Environmental leadership roles at the White House Council on Environmental Quality, U.S. Air Force, U.S. Environmental Protection Agency, and California Attorney General's Office and the practice of law in the private and public sectors; Visiting Professor and Lecturer, Paris School of International Affairs, SciencesPo (2018-2021); Co-author, Collaborating for Climate Resilience (2021); contributor, Smarter New York City (2019).

Christopher Patusky,J.D. Vice Chairman of the Board and Lead Independent Director
Age 62 · Total comp. $541,312.00 · As of 28 Apr 2026
Background

Mr. Christopher Patusky,J.D., Patusky Associates, LLC, personal investment firm - Founding Principal (2012-present); Maryland Department of Transportation -Real Estate Director (2007-2011); oversight responsibility for real estate policy for all modes of transportation, service on the department's sustainability committee, and implementation of the Governor's Transit Oriented Development program; University of Pennsylvania, Fels Institute of Government - Executive Director & Faculty Member (2002-2007); directed the implementation of an innovative performance management system for the 270 schools of the Philadelphia School District, which was recognized by the IBM Business of Government awards program. Other Professional Experience and Achievements: Executive Manager of Slater Run Vineyards, LLC, family's farm-based vineyard and winery; Private legal practice focusing on litigation, intellectual property, and business startups (1988-2000); co-led team that obtained the first approval from the Federal Communications Commission and the United Nations' International Telecommunications Union of the use of stratospheric stations for delivery of telecommunication services worldwide. Education: B.S., History & Political Science, Northwestern University; J.D., Harvard Law School; Master's in Governmental Administration, University of Pennsylvania.

Christopher Causey,M.B.A. Independent Director
Age 63 · Total comp. $508,034.00 · As of 28 Apr 2026
Background

Mr. Christopher Causey,M.B.A., Career Highlights: Causey Consortium, professional services organization providing business strategy and marketing counsel to the healthcare industry - Principal (2002-2021); Definity Health Incorporated, a consumer-driven health plan operator - Chief Marketing Officer (2001-2002); Allina Health System, a healthcare system based in Minneapolis, Minnesota - Vice President, Marketing and Communications (1997-2000). Other Professional Experience and Achievements: Board of Trustees of The?College of Wooster (2015-present); Member, Board of Directors, Data Sciences International, Inc. (2008-2013). Education: B.A., Psychology, College of Wooster; M.B.A., George Washington University.

Richard Giltner Independent Director
Age 62 · Total comp. $501,397.00 · As of 28 Apr 2026
Background

Mr. Richard Giltner, Career Highlights: Lyxor Asset Management, an asset management group at Societe Generale - Portfolio Manager (2009-2010); Societe Generale, a European financial services company - Managing Director of Societe Generale Asset Management and head of the European office for its fund of hedge funds group (2006-2009); Global Head of Foreign Exchange Options, Investment Banking Division (2003-2006); Various managerial roles (1991-2003). Other Professional Experience and Achievements: Private Investor (since 2010 following retirement from Lyxor Asset Management). Education: B.A., Economics, Northwestern University.

Dr. Louis W. Sullivan, M.D. Independent Director
Age 92 · Total comp. $499,127.00 · As of 28 Apr 2026
Background

Dr. Sullivan was the founding President of Morehouse School of Medicine, from 1981 to 1989, served as President again from 1993 to 2002, and has served as President Emeritus since 2002. Dr. Sullivan was also one of the founders and served as Chair of Medical Education for South African Blacks, Inc., a member of the National Executive Council for the Boy Scouts of America, and a member of the Board of Trustees of Little League of America. Dr. Sullivan served as Secretary of the U.S. Department of Health and Human Services from 1989 to 1993. He is a physician certified in internal medicine with a sub-specialty certification in hematology. Dr. Sullivan currently serves on the board of directors of Emergent BioSolutions, Inc. (since 2005), a publicly-traded company. He also serves as Co-Chair of the Henry Schein Cares Foundation. Dr. Sullivan previously served on the boards of directors of a wide range of public companies, including General Motors Company, BioSante Pharmaceuticals, Inc., Bristol Myers Squibb Company, Cigna Corporation, 3M Company, Henry Schein, Inc., Household International (now HSBC), Equifax, and Georgia Pacific Corporation. Dr. Sullivan received his bachelor's degree from Morehouse College, and his medical degree from Boston University.

Dr. Linda Maxwell, M.B.A.,M.D. Independent Director
Age 52 · Total comp. $489,556.00 · As of 28 Apr 2026
Background

Dr. Linda Maxwell, M.B.A.,M.D., Career Highlights: DCVC, Silicon Valley venture capital firm - Operating Partner (2022-Present). University of Toronto - Adjunct Professor of Surgery; Visiting Professor at Toronto Metropolitan University; Associate Scientist at the Li Ka Shing Knowledge Institute (2015-2024); Triple board certified in Otolaryngology-Head Neck Surgery, Facial Plastic Reconstructive Surgery, and Obesity Medicine. University of Oxford and UK National Health Service - Managed life sciences tech transfer portfolio.Other Professional Experience and Community Involvement: Served as a healthcare innovation expert to various Canadian federal, provincial, and local government entities; Founding and Executive Director, Biomedical Zone, Canada's leading hospital-embedded, physician-led business incubator for emerging health technology companies (2015); Former Member, Board of Directors, Profound Medical Inc., a publicly traded company; NACD.DC and ICD.D designations, certifications issued in the U.S. and Canada, respectively, to corporate directors; completed Diligent Climate Leadership Certificate. Other Current Public Company Boards: ImmunityBio, Inc. Education:B.A., Biology, Harvard College; M.D., Yale Medical School; M.B.A., Oxford University.

Governor Tommy G. Thompson, J.D. Independent Director
Age 84 · Total comp. $483,034.00 · As of 28 Apr 2026
Background

Before entering the private sector in 2005, Governor Thompson enjoyed a long and distinguished career in public service. As Secretary of the U.S. Department of Health and Human Services from 2001 to 2005, he was a leading advocate for the health and welfare of all Americans. He also served four terms as Governor of Wisconsin from 1987 to 2001. Governor Thompson served as Interim President of the University of Wisconsin System from July 2020 through March 2022. Governor Thompson served as a partner at the law firm of Akin Gump Strauss Hauer & Feld LLP in Washington, D.C. from 2005 until January 2012, and as an Adjunct Senior Advisor from 2017 to 2020. From 2005 to 2009, he also served as the Independent Chair of the Deloitte Center for Health Solutions, which researches and develops solutions to some of our nation's most pressing health care and public health related challenges. He currently serves on the boards of directors of Healthpeak Properties, Inc. and TherapeuticsMD, Inc., each of which is publicly-traded. He resigned as executive chair of the TherapeuticsMD board in March 2024, and was re-appointed as the non-executive chair of the TherapeuticsMD board. He previously served on the boards of various other public companies, including AGA Medical Holdings, Inc., Cancer Genetics Inc., CareView Communications, Inc., Centene Corporation, CNS Response, Inc., C.R. Bard, Inc., Cytori Therapeutics, Inc., Scilex Holding Company, Physicians Realty Trust, SpectraScience, Tyme Technologies, Inc., and X Shares Advisors. Governor Thompson earned his bachelor and juris doctor degrees from the University of Wisconsin-Madison.Other Current Public Company Boards: Healthpeak Properties, Inc.; TherapeuticsMD, Inc.; Vector Science & Therapeutics.

Dr. Judy D. Olian, PhD Independent Director
Age 74 · Total comp. $476,397.00 · As of 28 Apr 2026
Background

Dr. Judy D. Olian, PhD, Career Highlights: Quinnipiac University - President (2018-2025); President Emerita (2025-present). UCLA Anderson School of Management - Dean; John E. Anderson Chair in Management (2006-2018); Pennsylvania State University - Dean and Professor, Smeal College of Business Administration (2001-2006). Other Professional Experience and Achievements: Advisory boards: U.S. Studies Centre (University of Sydney); Peking University Business School; Connecticut Governor's Workforce Council; Business-Higher Education Forum; New Haven Promise; Catalyst; Co-Chair, AdvanceCT (2024-present); Board Member, Hartford Healthcare (2022-present) and Wisconsin Alumni Research Foundation (2025-present). Other Current Public Company Boards: Ares Management; Mattel, Inc. Education: B.S., Psychology, Hebrew University of Jerusalem; M.S., Industrial Relations, University of Wisconsin-Madison; Ph.D., Industrial Relations, University of Wisconsin-Madison.

Jan Malcolm Independent Director
Age 70 · Total comp. $470,265.00 · As of 28 Apr 2026
Background

Ms. Jan Malcolm, Career Highlights: Minnesota Department of Health: Commissioner of Health (1999-2003; 2018-2023); Courage Center, leading provider of rehabilitation and health services for people with disabilities serving over 12,000 patients annually - Chief Executive Officer (2005-2013); Allina Health System: Vice President (1994-1999; 2013-2016); Former Board Member: Blue Cross Blue Shied of Minnesota; United Way of Minnesota; Bush Foundation. Other Professional Experience and Community Involvement: Adjunct Faculty, University of Minnesota School of Public Health (2016-2024); Co-Director, Robert Wood Johnson Foundation program (2016-2018); Recipient, AMA Award for Outstanding Government Service from the American Medical Association (2024); Honorary doctor of laws degree from the University of Minnesota; honorary doctor of human letters degree from Saint Catherine University. Education: B.A., Philosophy and Psychology, Dartmouth College.

Raymond C. Kurzweil Independent Director
Age 78 · Total comp. $463,743.00 · As of 28 Apr 2026
Background

Mr. Raymond C. Kurzweil, Career Highlights: Kurzweil Technologies, Inc., a technology development firm - Chief Executive Officer (1995-present); Beyond Imagination, a humanoid robotics company - Chief AI Officer (2025-present); Co-Founder (2018). Google - Principal Researcher and AI Visionary (2023-2025); Director of Engineering (2013-2023). Other Professional Experience and Achievements: Inducted into the National Inventors Hall of Fame (2002); Recipient of the National Medal of Technology, MIT Lemelson Prize, Grammy Award, 21 honorary doctorates, and honors from three U.S. presidents; Previously served as a member of the boards of directors of Inforte Corp. and Medical Manager Corporation, both of which were publicly traded. Education: B.S., Computer Science and Literature, Massachusetts Institute of Technology.

Dr. Victor J. Dzau,M.D. Director
As of 22 Jul 2026
Background

On July 22, 2026, the Board of Directors of United Therapeutics Corporation appointed Victor Dzau, M.D., to serve as a member of the Board. Dr. Dzau recently completed a 12-year tenure as President of the National Academy of Medicine (NAM) and formerly served as Chancellor for Health Affairs at Duke University, President and CEO of the Duke University Health System, and Chairman of Medicine at Harvard and Stanford Universities. His term with NAM expired at the end of June 2026, and in July 2026 he returned to Duke University as James B. Duke Distinguished Professor of Medicine, Chancellor Emeritus for Health Affairs, and Director of the Mandel Center. He also serves as Co-Chair of the G20 High-Level Independent Panel on Financing Pandemic Preparedness and Response.

Kevin J. Tracey, M.D. Director
As of 21 Jan 2026
Background

Kevin J. Tracey has been appointed to the board as director with effect from 21st Jan 2026. Dr. Tracey is President, CEO, and the Karches Family Distinguished Chair in Medical Research at The Feinstein Institutes for Medical Research. He is a Professor of Molecular Medicine and Neurosurgery at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and Executive Vice President, Research, at Northwell Health. A leader in the scientific fields of inflammation and bioelectronic medicine, Dr. Tracey's contributions include discovery and molecular mapping of neural circuits controlling immunity, as well as identifying the therapeutic action of monoclonal anti-TNF antibodies. Dr. Tracey is the co-founder of several biotechnology companies, including SetPoint Medical, the industry leader in bioelectronic medicine.

From SEC filings, via Futu. Compensation is total reported pay for the most recent fiscal year on file, not base salary alone.

Sectors & themes

Discussion

No comments yet — be the first to weigh in on UTHR.

Sign in to join the discussion.

Scroll to Top